Spun out of Tufts University, PhagePro Inc is a discovery-driven small firm working with bacteriophages: viruses that specifically target and kill bacteria thereby preventing bacterial infections. With the unmitigated rise of antibiotic resistance and the known negative consequences of gut dysbiosis caused by broad-spectrum antibiotics, bacteriophages offer and provide a side-effect-free alternative for preventing disease in clinical and community contexts.